A health economic evaluation of the multinational, randomized controlled CONVINCE trial : cost-utility of high-dose online hemodiafiltration compared to high-flux hemodialysis
High-flux hemodialysis (HD) and high-dose hemodiafiltration (HDF) are established treatments for patients with kidney failure. Since HDF has been associated with improved survival rates compared to HD, we evaluated the cost-effectiveness of HDF compared to HD. Cost–utility analyses were performed from a societal perspective alongside the multinational randomized controlled CONVINCE trial. A Markov
